Mentice publishes Annual Report 2024

Mentice Secures $648,410 USD Combined Order for Advanced Simulation Solutions from a Top 20 Global MedTech company

Mentice has received a significant order from a key distributor in APAC

Wednesday, September 20, 2023

Mentice (publ), a global leader in simulation solutions for image-guided interventional therapies, announced today that a prominent distributor in the APAC region has signed an agreement to acquire Mentice VIST® simulation solutions for 592,000 EUR.

"As the healthcare market in APAC continues to develop, there is an increasing demand for endovascular simulation solutions. This recent order is a testament to the commitment of our regional partners to Mentice and our innovative solutions," stated Göran Malmberg.

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB